• Info
  • Insider Ownership

Insider Trading & Ownership of Thomas Malley

Location
Hamilton, Bermuda
Summary
The estimated net worth of Thomas Malley is at least $17,504,479 dollars as of 14 Aug 2025. Thomas Malley is the Director of BeiGene, Ltd. and owns shares of BeiGene, Ltd. (ONC) stock worth about $15,114,558. Thomas Malley is the Director of Kiniksa Pharmaceuticals International, plc and owns shares of Kiniksa Pharmaceuticals International, plc (KNSA) stock worth about $2,389,921.
Signature
/s/ Madelyn Zeylikman, Attorney-in-Fact
All Insider Reports
All Insider Reports

Notify me when Thomas Malley files a new Insider Trading report.

⭐ Subscribe ⭐

Ownership of Thomas Malley

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
ONC, BEIGF BeiGene, Ltd. Director $15,114,558 15 Jun 2023
KNSA Kiniksa Pharmaceuticals International, plc Director $2,389,921 -$5,859,815 -71% 12 Aug 2025
KURA Kura Oncology, Inc. Director 05 Jun 2025

Insider Transactions Reported by Thomas Malley:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.